Dirk Schadendorf - Curriculum Vitae#
Position
Director & Chair Department of Dermatology & Director, Comprehensive Cancer Center (Westdeutsches Tumorzentrum), University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany, Tel. (49) 201 723 2430, Dirk.Schadendorf@uk-essen.de
RESEARCH FIELD
Tumor biology (Melanoma and other skin-originated tumors), Tumor immunology, Targeted therapy, Translational and clinical research with an emphasis on therapy and biomarkers
EDUCATION & TRAINING
- 1980 - 1986 Medical School, University of Hamburg
- 1986 - 1989 Postdoctoral Fellowship at MemorialSloan Kettering Cancer Center, New York
- 1989 Max Planck Institute of Molecular Genetics, Berlin
POSITIONS & EMPLOYMENT
- 1989 - 1994 Residency Training in Dermtology, Uiversity Hospital Rudolf Virchow, Berlin
- 1994 - 1995 Attending Physician, Charié Berlin
- 1996 - 1997 DFG-Heisenberg Stipend
- 1997 - 2008 Department Head, Skin Cancer Unit at DKFZ, Heidelberg
- since 7/2008 Director & Chair Department of Dermatology, University Hospital Essen
- since 2013 Managing Director of the West German Tumor Center WTZ (CCC), Essen
ACTIVITIES IN THE SCIENTIFIC COMMUNITY AND OTHER EXPERIENCES
- since 2018 Founding member of European Melanoma Registry (EuMelaReg) https://www.eumelareg.org
- since 2017 Highly Cited Researcher in the field of Clinical Medicine (web of Science)
- since 2013 Founding member of German Skin Cancer Registry (https://www.hautkrebsregister.de)
- since 2014 President of the Nationale Versorgungskonferenz Hautkrebs
- since 1998 Member of Steering Cie EORTC Melanoma Group acc by various Officier positions
- since 1995 Member of the German DeCOG/Dermatologic Cooperative Oncology Group/Arbeitsgemeinschaft Dermatol. Onkologie/ADO)
- since 01/2012 Council Member of the German Cancer Society/Deutsche Krebsgesellschaft (DKG))
- since 5/2013 Director of the West German Cancer Center at the University Hospital Essen / Westdeutsches Tumorzentrums (WTZ) am Universitatsklinikum Essen
- since 1998 Coordinator of several national & international Research associations (among others OISTER, GenoMel, ENACT, (EU 4th to 7th framework, HORIZON ), German Cancer Aid/DKH-tumor banks/MelaConsort)
